A PHASE II TRIAL AIMING TO INVESTIGATE THE SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN IN ADULT PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA PREVIOUSLY TREATED WITH A THROMBOPOIETIN RECEPTOR AGONIST AND/OR RITUXIMAB AFTER CORTICOSTEROID FIRST-LINE THERAPY
Clinical trial NCT07019545 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07019545
- Sponsor
- Hellenic Society of Hematology
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-20
- Primary completion
- 2026-06-20
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.